Prakhar Agrawal
Stock Analyst at Cantor Fitzgerald
(4.02)
# 1,797
Out of 5,184 analysts
119
Total ratings
33.9%
Success rate
10.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Prakhar Agrawal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TRXB TRex Bio | Initiated Coverage: Buy | $31 | $10.32 | +200.53% | 1 | Nov 3, 2026 | |
| TVTX Travere Therapeutics | Reiterated: Buy | n/a | $47.00 | - | 8 | Nov 3, 2026 | |
| ORIC ORIC Pharmaceuticals | Reiterated: Buy | n/a | $7.36 | - | 7 | Oct 27, 2026 | |
| EVMN Evommune | Reiterated: Buy | n/a | $7.04 | - | 2 | Sep 17, 2026 | |
| IVA Inventiva | Initiated Coverage: Buy | n/a | $3.14 | - | 1 | Jul 17, 2026 | |
| SLN Silence Therapeutics | Initiated Coverage: Buy | n/a | $19.81 | - | 1 | Jun 24, 2026 | |
| GPCR Structure Therapeutics | Reiterated: Buy | $101 | $16.13 | +526.16% | 10 | Jun 7, 2026 | |
| STTK Shattuck Labs | Initiated Coverage: Buy | n/a | $4.46 | - | 1 | Apr 27, 2026 | |
| MANE Veradermics | Initiated Coverage: Buy | n/a | $119.52 | - | 1 | Mar 1, 2026 | |
| MLTX MoonLake Immunotherapeutics | Reiterated: Buy | n/a | $11.07 | - | 9 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $379.10 | n/a | 4 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.44 | n/a | 2 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.82 | n/a | 10 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $6.76 | n/a | 1 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.99 | n/a | 1 | Jul 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $38.66 | n/a | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $41.37 | n/a | 3 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $63.34 | n/a | 6 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $11.08 | n/a | 2 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $2.8 | $1.06 | n/a | 10 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.22 | n/a | 2 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $3.5 | $1.66 | n/a | 3 | Jan 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $23 | $3.99 | n/a | 8 | Sep 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 → $62 | $4.66 | n/a | 8 | Oct 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $26.36 | n/a | 8 | Sep 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $0.84 | n/a | 8 | Aug 5, 2021 |
TRex Bio
Nov 3, 2026
Initiated Coverage: Buy
Price Target: $31
Current: $10.32
Upside: +200.53%
Travere Therapeutics
Nov 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $47.00
Upside: -
ORIC Pharmaceuticals
Oct 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.36
Upside: -
Evommune
Sep 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.04
Upside: -
Inventiva
Jul 17, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $3.14
Upside: -
Silence Therapeutics
Jun 24, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $19.81
Upside: -
Structure Therapeutics
Jun 7, 2026
Reiterated: Buy
Price Target: $101
Current: $16.13
Upside: +526.16%
Shattuck Labs
Apr 27, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $4.46
Upside: -
Veradermics
Mar 1, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $119.52
Upside: -
MoonLake Immunotherapeutics
Dec 4, 2025
Reiterated: Buy
Price Target: n/a
Current: $11.07
Upside: -
Nov 4, 2025
Upgraded: Buy
Price Target: n/a
Current: $379.10
Upside: n/a
Oct 15, 2025
Reiterated: Buy
Price Target: n/a
Current: $3.44
Upside: n/a
Sep 15, 2025
Downgraded: Hold
Price Target: n/a
Current: $3.82
Upside: n/a
Aug 15, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $6.76
Upside: n/a
Jul 7, 2025
Reiterated: Buy
Price Target: n/a
Current: $2.99
Upside: n/a
Jun 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $38.66
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $41.37
Upside: n/a
Mar 3, 2025
Reiterated: Buy
Price Target: n/a
Current: $63.34
Upside: n/a
Jan 21, 2025
Downgraded: Hold
Price Target: n/a
Current: $11.08
Upside: n/a
Aug 11, 2023
Reiterated: Buy
Price Target: $14 → $2.8
Current: $1.06
Upside: n/a
Mar 17, 2023
Rated: Hold
Price Target: n/a
Current: $1.22
Upside: n/a
Jan 10, 2023
Reiterated: Buy
Price Target: $5 → $3.5
Current: $1.66
Upside: n/a
Sep 12, 2022
Reiterated: Buy
Price Target: $27 → $23
Current: $3.99
Upside: n/a
Oct 18, 2021
Reiterated: Buy
Price Target: $58 → $62
Current: $4.66
Upside: n/a
Sep 21, 2021
Reiterated: Buy
Price Target: $44
Current: $26.36
Upside: n/a
Aug 5, 2021
Reiterated: Buy
Price Target: $22
Current: $0.84
Upside: n/a